|
US5885971A
(en)
*
|
1995-03-24 |
1999-03-23 |
The Regents Of The University Of California |
Gene therapy by secretory gland expression
|
|
US6531455B1
(en)
*
|
1995-03-24 |
2003-03-11 |
The Regents Of The University Of California |
Delivery of polynucleotides by secretory gland expression
|
|
US20020037867A1
(en)
*
|
1999-02-26 |
2002-03-28 |
James M. Wilson |
Method for recombinant adeno-associated virus-directed gene therapy
|
|
CA2265460A1
(en)
|
1996-09-11 |
1998-03-19 |
The Government Of The United States Of America, Represented By The Secre Tary, Department Of Health And Human Services |
Aav4 vector and uses thereof
|
|
US6797505B2
(en)
*
|
1998-05-27 |
2004-09-28 |
Cell Genesys, Inc. |
Recombinant AAV vectors for gene therapy of hemophilia A
|
|
US6984517B1
(en)
|
1998-05-28 |
2006-01-10 |
The United States Of America As Represented By The Department Of Health And Human Services |
AAV5 vector and uses thereof
|
|
EP1082413B1
(en)
*
|
1998-05-28 |
2008-07-23 |
THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES |
Aav5 vector and uses thereof
|
|
US6759237B1
(en)
*
|
1998-11-05 |
2004-07-06 |
The Trustees Of The University Of Pennsylvania |
Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same
|
|
ES2340230T3
(es)
|
1998-11-10 |
2010-05-31 |
University Of North Carolina At Chapel Hill |
Vectores viricos y sus procedimientos de preparacion y administracion.
|
|
US6503887B1
(en)
*
|
1999-02-19 |
2003-01-07 |
Matthew During |
Peroral gene therapy of diabetes and obesity
|
|
WO2000074688A1
(en)
*
|
1999-06-08 |
2000-12-14 |
The Children's Hospital Of Philadelphia |
Methods for preventing formation of inhibitory antibodies in the setting of gene therapy
|
|
US6610906B1
(en)
*
|
1999-06-09 |
2003-08-26 |
The Regents Of The University Of Michigan |
Nucleotide sequences for gene regulation and methods of use thereof
|
|
WO2001049118A1
(en)
*
|
2000-01-03 |
2001-07-12 |
Panagenic International, Inc. |
Compositions comprising genome segments and methods of using the same
|
|
US6855314B1
(en)
|
2000-03-22 |
2005-02-15 |
The United States Of America As Represented By The Department Of Health And Human Services |
AAV5 vector for transducing brain cells and lung cells
|
|
US7201898B2
(en)
*
|
2000-06-01 |
2007-04-10 |
The University Of North Carolina At Chapel Hill |
Methods and compounds for controlled release of recombinant parvovirus vectors
|
|
US20020106381A1
(en)
*
|
2000-06-13 |
2002-08-08 |
High Katherine A. |
Methods for administering recombinant adeno-associated virus virions to humans previously exposed to adeno-associated virus
|
|
AU2002226028A1
(en)
*
|
2000-11-14 |
2002-05-27 |
Board Of Regents, Unversity Of Texas Systems |
Mutant human factor ix with an increased resistance to inhibition by heparin
|
|
US6794376B2
(en)
*
|
2000-12-06 |
2004-09-21 |
William Beaumont Hospital |
Methods and compositions for enhancing diffusion of therapeutic agents through tissue
|
|
US20020159978A1
(en)
*
|
2001-02-06 |
2002-10-31 |
James Allen |
Muscle-directed gene transfer by use of recombinant AAV-1 and AAV-6 virions
|
|
EP1418810A4
(en)
|
2001-08-03 |
2006-08-02 |
Us Gov Health & Human Serv |
TREATMENT OF HEMOPHILIA ORAL
|
|
PT1567641E
(pt)
|
2001-08-24 |
2012-08-21 |
Uvic Industry Partnerships Inc |
Proaerolisina contendo sequência de activação de proteases e métodos de uso para o tratamento do cancro da próstata
|
|
US20030198620A1
(en)
*
|
2002-04-16 |
2003-10-23 |
Keiya Ozawa |
Method of treating amino acid metabolic disorders using recombinant adeno-associated virus virions
|
|
US7419817B2
(en)
|
2002-05-17 |
2008-09-02 |
The United States Of America As Represented By The Secretary Department Of Health And Human Services, Nih. |
Scalable purification of AAV2, AAV4 or AAV5 using ion-exchange chromatography
|
|
US20040092008A1
(en)
*
|
2002-11-12 |
2004-05-13 |
Snyder Richard O. |
Recombinant AAV vectors for gene therapy of hemophilia A
|
|
WO2005017101A2
(en)
|
2003-05-19 |
2005-02-24 |
THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH & HUMAN SERVICES, NATIONAL INSTITUTES OF HEALTH |
Avian adenoassociated virus (aaav) and uses thereof
|
|
SI3235827T1
(sl)
|
2003-06-19 |
2021-05-31 |
Genzyme Corporation |
AAV virioni z zmanjšano imunoreaktivnostjo in uporaba za ta namen
|
|
WO2005056807A2
(en)
|
2003-12-04 |
2005-06-23 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services, National Institutes Of Health |
Bovine adeno-associated viral (baav) vector and uses thereof
|
|
WO2005077333A2
(en)
*
|
2004-02-10 |
2005-08-25 |
University Of Florida Research Foundation, Inc. |
Gel-based delivery of recombinant adeno-associated virus vectors
|
|
US7722596B2
(en)
*
|
2004-02-26 |
2010-05-25 |
Osprey Medical, Inc. |
Regional cardiac tissue treatment
|
|
EP1804839B1
(en)
|
2004-09-22 |
2012-03-14 |
St. Jude Children's Research Hospital |
Improved expression of factor ix in gene therapy vectors
|
|
EP1828390B1
(en)
|
2004-12-15 |
2012-06-13 |
The University Of North Carolina At Chapel Hill |
Chimeric vectors
|
|
WO2006089340A2
(en)
*
|
2005-02-23 |
2006-08-31 |
V-Kardia Pty Ltd |
Polynucleotide delivery to cardiac tissue
|
|
US8283151B2
(en)
|
2005-04-29 |
2012-10-09 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Isolation, cloning and characterization of new adeno-associated virus (AAV) serotypes
|
|
US8152786B2
(en)
*
|
2006-11-07 |
2012-04-10 |
Osprey Medical, Inc. |
Collection catheter and kit
|
|
US9050400B2
(en)
*
|
2008-08-12 |
2015-06-09 |
Osprey Medical, Inc. |
Remote sensing catheter system and methods
|
|
US20100041984A1
(en)
*
|
2008-08-12 |
2010-02-18 |
James Edward Shapland |
Impedance sensing device and catheter system
|
|
EP2396343B1
(en)
|
2009-02-11 |
2017-05-17 |
The University of North Carolina At Chapel Hill |
Modified virus vectors and methods of making and using the same
|
|
FR2952374B1
(fr)
*
|
2009-11-06 |
2012-11-16 |
Univ Claude Bernard Lyon |
Production de facteur ix recombinant dans une lignee cellulaire hepatocytaire humaine
|
|
WO2011057243A2
(en)
*
|
2009-11-09 |
2011-05-12 |
University Of Central Florida Research Foundation, Inc. |
Administration of plant expressed oral tolerance agents
|
|
KR20130028044A
(ko)
*
|
2009-12-08 |
2013-03-18 |
헬스 리서치 인코포레이티드 |
보조제로서 퍼옥시레독신1 (ｐｒｘ１)을 사용하는 방법 및 조성물
|
|
US9295816B2
(en)
*
|
2009-12-09 |
2016-03-29 |
Osprey Medical, Inc. |
Catheter with distal and proximal ports
|
|
DK2529020T3
(en)
*
|
2010-01-28 |
2018-08-06 |
Childrens Hospital Philadelphia |
SCALABLE PREPARATION PLATF FOR CLEANING VIRAL VECTORS AND CLEANED VIRAL VECTORS FOR USE IN GENTHERAPY
|
|
EP2627665B1
(en)
|
2010-10-12 |
2015-12-16 |
The Children's Hospital Of Philadelphia |
Methods and compositions for treating hemophilia B
|
|
PL3586861T3
(pl)
|
2011-06-08 |
2022-05-23 |
Translate Bio, Inc. |
Kompozycje nanocząstek lipidowych i sposoby dostarczania mrna
|
|
WO2012177778A1
(en)
|
2011-06-20 |
2012-12-27 |
Mount Sinai School Of Medicine |
Anti-tnf- therapy for the mucopolysaccharidoses and other lysosomal disorders
|
|
US9211372B2
(en)
|
2011-08-11 |
2015-12-15 |
Osprey Medical, Inc. |
Systems and methods for limb treatment
|
|
HK1222673A1
(zh)
*
|
2013-07-12 |
2017-07-07 |
The Children's Hospital Of Philadelphia |
Aav载体和用於抗aav(腺相关病毒)中和抗体的检测
|
|
BR112016019940A2
(pt)
|
2014-03-21 |
2017-10-24 |
Univ Leland Stanford Junior |
edição de genoma sem nucleases
|
|
GB201420139D0
(en)
|
2014-11-12 |
2014-12-24 |
Ucl Business Plc |
Factor IX gene therapy
|
|
WO2017100676A1
(en)
*
|
2015-12-11 |
2017-06-15 |
The Trustees Of The University Of Pennsylvania |
Scalable purification method for aav8
|
|
KR102415992B1
(ko)
|
2016-04-15 |
2022-07-04 |
다케다 야쿠힌 고교 가부시키가이샤 |
약물동역학 약물 투약 요법을 제공하는 방법 및 장치
|
|
US10896749B2
(en)
|
2017-01-27 |
2021-01-19 |
Shire Human Genetic Therapies, Inc. |
Drug monitoring tool
|
|
CN110945127B
(zh)
|
2017-05-22 |
2024-07-12 |
武田药品工业株式会社 |
用于血友病b的基因疗法的编码具有增加的表达的重组fix的病毒载体
|
|
WO2019083171A2
(ko)
|
2017-10-26 |
2019-05-02 |
주식회사 큐로진생명과학 |
솔루블 vegfr-1 변이체 cdna를 함유하는 raav를 포함하는 황반변성 치료용 조성물
|
|
US10842885B2
(en)
|
2018-08-20 |
2020-11-24 |
Ucl Business Ltd |
Factor IX encoding nucleotides
|
|
GB201813528D0
(en)
|
2018-08-20 |
2018-10-03 |
Ucl Business Plc |
Factor IX encoding nucleotides
|
|
JP7578590B2
(ja)
|
2018-10-18 |
2024-11-06 |
インテリア セラピューティクス，インコーポレーテッド |
第ｉｘ因子を発現するための組成物及び方法
|